Top Wall Street Analyst Adjusts MiniMed Q1 Earnings Forecast

MiniMed Group, Inc. will release its first-quarter earnings before the market opens on September 1.

Analysts expect the Northridge, California-based company to report earnings per share of 9 cents, compared to 35 cents per share in the same quarter last year. The consensus estimate for MiniMed's quarterly revenue is $828.4 million, versus $3.03 billion in the year-ago period.

On June 29, MiniMed appointed Alcon CEO David Endicott and Linnea Burman to its board of directors.

MiniMed Group shares rose 0.1% to $19.51 on Thursday. Readers can view the latest analyst ratings on the Analyst Stock Ratings page, filtering by stock ticker, company name, analyst firm, rating changes, or other criteria.

Let's see how the most accurate analysts in the near term have rated the stock.

Wells Fargo analyst Larry Biegelsen maintained an Overweight rating on June 4, 2026, and lowered the price target from $26 to $22. Biegelsen has a 66% accuracy rate.

BofA Securities analyst Travis Steed maintained a Buy rating on May 18, 2026, and significantly lowered the price target from $27 to $20. Steed has a 55% accuracy rate.

Barclays analyst Matt Miksic initiated coverage on April 1, 2026, with an Overweight rating and a $26 price target. Miksic has a 64% accuracy rate.

William Blair analyst Steven Lichtman initiated coverage on March 31, 2026, with an Outperform rating. Lichtman has a 56% accuracy rate.

Citi analyst Joanoe Wuensch initiated coverage on March 31, 2026, with a Buy rating and a $23 price target. Wuensch has a 71% accuracy rate.

Considering a position in MMED stock? Here's what the analysts think.